Heidelberg shows signs of recovery – EBITDA increases to €55 million

Sales expected at €2.3 billion for FY 2022-23, up from €2.183 billion last year

902
Heidelberg has improved its sales and result for the first half-year of 2022.
Heidelberg has improved its sales and result for the first half-year of 2022.

Heidelberg’s Packaging division saw the best results, with sales up from €221 million in Q2 last year to €291 million in Q2 this year, and up from €415 million in the first half of the previous year to €535 million this half. This equates to Earnings Before Interest, Taxes, Depreciation and Amortisation of €38 million for Q2 this year, up from €11 million in the same period last year. The EBITDA result for the first half rose from €17 million last year to €55 million for this year. 

In contrast, the Print Solutions division saw its orders for this year’s Q2 stay static at €334 million, the same as the previous year, while the figures fell for the half as a whole, from €689 million last year to €682 million this year. The EBITDA fell from €48 million in Q2 last year to €33 million this year, though this is mainly because the previous year’s figures included non-recurring income from the sale of its Docufy subsidiary. This means that the EBITDA for the first half also fell slightly from €55 million to €53 million this year.

Wallbox EV charging systems runs into loss territory

Heidelberg’s Technology Solutions, the division that covers the Wallbox EV charging systems, also saw its sales down markedly, from €12 million in Q2 last year to €6 million this quarter. The half year picture shows orders of €16 million, down on the €21 million from last year’s first half. This means that the EBITDA has fallen from €1 million in Q2 last year to a loss of €-3 million this quarter, and from €2 million for the first half of last year to a loss of €-4 million in this year’s H1. This is mostly due to the end of funding for private charging stations in Germany, together with longer delivery times for new electric cars.

Net sales for the first half of the year are up 14% on last year’s H1 figures to €1120 million, though Heidelberg acknowledged this was in part due to favourable exchange rates. Heidelberg says that its incoming orders for the company as a whole are 5% up for Q2 on last year’s figures to €622 million. For the first half, the orders stand at €1229 million, which leaves Heidelberg with an order backlog over €1 billion. This has led to some optimism regarding the company’s prospects for the full year, despite likely rising costs for energy and staffing.

The free cash flow for the first half fell from last year’s figure of €74 million to €–13 millionths year, mainly due to the usual production-related increase in inventories. This is mostly from Q2, which saw a drop from €45 million to €-12 million. In addition, revenues from the sale of assets in the first half-year also fell.

The half-year net financial debt was €23 million, which Heidelberg says is partly due  to the negative free cash flow. However, the company has improved its equity ratio, which is partly due to the higher actuarial interest rate for pensions in Germany as well as the rise in the quarterly profit to around 20 percent. The net result after taxes for the second quarter was €39 million, up from €27 million the previous year, and for the first half it stood at €44 million, up from €13 million last year. 

Heidelberg’s CEO, Dr Ludwin Monz, commented: “Despite a difficult environment, we have successfully overcome the challenges in the first half-year and achieved further growth. We remain cautious, though, because it’s not yet entirely clear how the global situation will develop.” He added: “During the first half-year, Heidelberg has laid a good foundation for achieving our financial targets. With this in mind, we are focusing on maintaining our supply chains, safeguarding our margin through higher sales prices, and continuing our cost discipline.” 

Consequently Heidelberg is still expecting its sales figures to increase to around €2.3 billion for the full year, up from €2.183 billion last year, though this obviously depends on the prevailing economic conditions. Heidelberg expects to see its own costs rising, but is confident that its EBITDA margin will rise to at least 8.0 percent for the year, up from last year’s 7.3 percent. The company expects the net result after taxes to improve slightly on last year’s €33 million.

The fastest growing democracy in the world could be a market for your products !

If you are confused by slow and poor sales to a seemingly large but immensely noisy and fragmented market, you are not alone! If your product is great, or viable, or appropriate, you can find your sweet spot in this more than US$ 4.3 trillion economy. The trick is to understand your potential and addressable markets, which we can help with in light of your direct competition. We understand marketing, communication, and sales strategies for market entry and growth.

If you are an OEM or a supplier with a strategy and budget, talk to us about using our hybrid print, web, video, and social media channels for locating and dominating your addressable markets in India and South Asia. We may be one of the world’s leading B2B publications in the print industry with hands-on practitioner and consulting experience. Our 50 years of domain knowledge observing technological change and understanding of business and financials, includes the best globally recognized technical writers. Apart from our industry award winners, an experienced team is ready to meet you and your customers for content.

India’s fast-growing economy and evolving democracy has considerable headroom for print. Get our 2026 media kit and recalibrate your role in this dynamic market.

Founded in 1979 as a technical newsletter, Indian Printer and Publisher is the oldest B2B trade publication in the multi-platform and multi-channel IPPGroup. IppStar [www.ippstar.org] is our Services, Training and Research organization.

Naresh Khanna – 12 January 2026

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here